MXE
methoxetamine, 3-meo-2'oxo-pce
Dissociative, Research-chemical, Habit-forming
A dissociative drug which is an analogue of ketamine. It is reported to be less sedating and more potent by weight. Anectodal reports indicate it has a subjectively more 'complicated' set of effects.
Methoxetamine is scheduled and or controlled in Brazil, Canada, China, EU, Finland, Israel, Japan, Poland, Russia, United Kingdom, United Nations, and the United States (among others).
NOTE: Bodyweight plays a slight factor in MXE dosing, these are values for a 175lb (80kg) male
Chart shows bounded mass ranges in mg. See the table for all doses.
Threshold
Light
Common
Strong
Heavy
Insufflated
5-10mg
10-20mg
20-35mg
35-60mg
60mg+
Oral
10-15mg
15-25mg
25-35mg
40-65mg
-
Sublingual
5-10mg
10-20mg
40-60mg
60-75mg
-
Onset
Insufflated
5m to 20m
Oral
30m to 1
Sublingual
15m to 45m
Combination information is sourced from our drug database. Sources can be found on our wiki. The nice combo chart can be found on tripsit.me/combo.
☠️ Dangerous ☠️
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Alcohol
There is a high risk of memory loss, vomiting and severe ataxia from this combination.
AMT
Diphenhydramine
There is a high risk of serotonin syndrome from this combination. Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position. MXE has a high likelihood of increasing DPH's deliriant effects at higher dosages and can greatly increase the risk of injury, mania, and psychosis. Medical dosages are unlikely to be of concern.
GHB/GBL
Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the individual falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.
Lithium
There is a risk of serotonin syndrome when combining Lithium with MXE, as Lithium can induce serotonin syndrome in conjunction with other serotonergic drugs, and MXE has shown a notable affinity for the serotonin transporter.
Opioids
This combination can potentiate the effects of the opioid
Tramadol
🛑 Unsafe 🛑
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Dextromethorphan
There is a risk of serotonin syndrome when combining DXM with MXE, due to DXM and MXE both being SRI’s. MXE and DXM having notable affinities for the serotonin transporter.
MAOIS
MAO-B inhibitors appear to increase the potency of MXE. MAO-A inhbitors have some negative reports associated with the combination but there isn't much information available
⚠️ Caution ⚠️
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
2C-T-X
Amphetamines
Risk of tachycardia, hypertension, and manic states
Benzodiazepines
Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. Place the affected individual in the recovery position to prevent vomit aspiration from excess.
Cocaine
Stimulants taken with MXE can lead to hypermanic states much more easily, especially if sleep is avoided.
DOX
As an NMDA antagonist MXE potentiates DOx which can be unpleasantly intense
MDMA
There have been reports of risky serotonergic interactions when the two are taken at the same time, but MXE taken to the end of an MDMA experience does not appear to cause the same issues.
NBOMES
As an NMDA antagonist MXE potentiates NBOMes which can be unpleasantly intense
PCP
There are no reports available about this combination
Pregabalin
Pregabalin and MXE may synergize and increase each other’s negative side effects such as nausea, dizziness, and loss of consciousness. Caution is advised for anything above low dosages due to seizure concerns, and all dosages for individuals with higher risk seizure profiles and or behavior.
SSRIS
Depending on the SSRI this combination can be unpredictable
↗ Low Risk & Synergy ↗
These drugs work together to cause an effect greater than the sum of its parts, and they aren't likely to cause an adverse or undesirable reaction when used carefully. Additional research should always be done before combining drugs.
2C-X
5-MEO-XXT
Little information exists about this combination.
Cannabis
DMT
Ketamine
LSD
Mescaline
Mushrooms
Nitrous
➡ Low Risk & No Synergy ➡
Effects are additive. The combination is unlikely to cause any adverse or undesirable reaction beyond those that might ordinarily be expected from these drugs.
Caffeine
No likely interactions
↘ Low Risk & Decrease ↘
Effects are subtractive. The combination is unlikely to cause any adverse or undesirable reaction beyond those that might ordinarily be expected from these drugs.
Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. - http://www.ncbi.nlm.nih.gov/pubmed/22578175Methoxetamine: from drug of abuse to rapid-acting antidepressant. - http://www.ncbi.nlm.nih.gov/pubmed/22819129From Special K to Special M: the evolution of the recreational use of ketamine and methoxetamine. - http://www.ncbi.nlm.nih.gov/pubmed/23421859Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn - http://www.ncbi.nlm.nih.gov/pubmed/23774830Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. - http://www.ncbi.nlm.nih.gov/pubmed/24580056Analytical findings of an acute intoxication after inhalation of methoxetamine. - http://www.ncbi.nlm.nih.gov/pubmed/24904014Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report - http://www.ncbi.nlm.nih.gov/pubmed/25060403From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine. - http://www.ncbi.nlm.nih.gov/pubmed/23421859Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn. - http://www.ncbi.nlm.nih.gov/pubmed/23774830Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report. - http://www.ncbi.nlm.nih.gov/pubmed/25060403~adddrugsource cannabis general Cannabis use in relation to obesity and insulin resistance in the Inuit population. - https://www.ncbi.nlm.nih.gov/pubmed/255573823 case reports of toxicity due to recreational use of MXE - http://link.springer.com/article/10.1007/s00228-011-1199-9http://www.azleg.gov/DocumentsForBill.asp?Session_ID=112&Bill_Number=HB2453http://www.leg.state.fl.us/Statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.htmlhttp://www.in.gov/legislative/ic/2010/title35/ar31.5/ch2.htmlhttp://www.legis.la.gov/legis/ViewDocument.aspx?d=850979&n=HB10%20Acthttps://www.revisor.mn.gov/statutes/?id=152.02http://www.legis.nd.gov/cencode/t19c03-1.pdf?20140721032549http://www.legislature.state.oh.us/BillText130/130_HB_315_RH_N.htmlhttp://www.legislation.gov.uk/uksi/2013/239/contents/made